Pluripotent Stem Cell-Derived Therapies
Each year, more human pluripotent stem cell(hPSC)-derived therapies move toward the clinic, which is why it’s important to stay up-to-date with the latest advancements in the field. Whether you’re just about to start your next project or are well on your way to clinical trials, the big picture of clinical translation in terms of patient safety, cell quality, and physiological relevance should always be top of mind.
Below is a collection of scientific resources to highlight the exciting potential of hPSC-derived therapies.
In this Innovation Showcase presentation, Lynn Csontos demonstrates how º£½ÇÆƽâ°æ can support your project timing, product quality, and overall vision by building quality into our products, processes, and policies. Kimberly Snyder then presents data showing how TeSRâ„¢-AOF, a novel animal origin-free (AOF) hPSC maintenance medium, supports optimized cell quality, improved performance, and reproducibility across all cell lines.
Watch Now >-
Nature Research Round Table: hPSC Lines for Cell Therapies - Panel DiscussionIn this panel discussion led by Dr. Christine Mummery from the Leiden University Medical Center, keynote speakers respond to questions from the forum and evaluate consensuses around topics raised in the previous talks. <br><br> This panel discussion was part of a Round Table series titled “<a href="/nature-research-roundtable-hPSC-quality#section-webcasts">Challenges in Ensuring hPSC Quality</a>â€, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series <a href="/nature-research-roundtable-hPSC-quality#section-webcasts">here</a>. -
Nature Research Round Table: Standards for Pluripotent Stem Cell BankingDr. Glyn Stacey, Director of the International Stem Cell Banking Initiative (ISCBI), discusses standards for pluripotent stem cell (PSC) banking with a focus on scientific challenges for PSCs, standardization of ethics, the role of stem cell biobanks, and best practices for cell therapy. This presentation and the following Q&A session were moderated by Dr. Joanne Mountford from the University of Glasgow. <br><br> This presentation was part of a Round Table series titled “<a href="/nature-research-roundtable-hPSC-quality#section-webcasts">Challenges in Ensuring hPSC Quality</a>â€, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series <a href="/nature-research-roundtable-hPSC-quality#section-webcasts">here</a>. -
How to Set Up an Assay with the hPSC Genetic Analysis Kit ExperimentAnalyze genomic DNA samples using the Human Pluripotent Stem Cell (hPSC) Genetic Analysis Kit
